Delivering new melanoma drugs to cost DHBs over $1 million

While Pharmac's decision to fund the hotly-debated melanoma drug Keytruda is being welcomed, cash-strapped district health boards face costs of more than a million dollars to deliver the long-awaited new drugs to patients.